Drug Shortage Report for VAQTA

Last updated on 2019-10-21 History
Report ID 56191
Drug Identification Number 02229702
Brand name VAQTA
Common or Proper name hepatitis A vaccine, purified inactivated Suspension for injection
Company Name MERCK CANADA INC
Active Ingredient(s) HEPATITIS A VACCINE, INACTIVATED
Strength(s) 50UNIT
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 50U/1ML 1DOSE VIAL
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date 2018-07-30
Actual start date 2018-07-27
Estimated end date 2019-12-31
Actual end date 2019-10-18
Shortage status Resolved
Updated date 2019-10-21
Company comments Remaining doses are reserved for the public immunization program. /Les doses restantes sont réservées au programme public de vaccination.
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2019-10-21 French Compare
v10 2019-10-21 English Compare
v9 2019-01-22 English Compare
v8 2018-12-17 English Compare
v7 2018-07-28 English Compare
v6 2018-07-27 French Compare
v5 2018-07-27 English Compare
v4 2018-07-25 English Compare
v3 2018-07-25 English Compare
v2 2018-07-23 French Compare
v1 2018-07-23 English Compare